Form 4: Agrify Director Krishnan Varier Reports RSU Vesting and Subsequent Share Sales

Sentiment:

Insider Transaction Report


Agrify Corp. Director Krishnan Varier reported the vesting of 5,000 restricted stock units and the subsequent sale of all those shares, alongside receiving a new RSU grant.

Summary

  • On June 11, 2025, Krishnan Varier, a Director of Agrify Corp. (AGFY), was granted 5,000 restricted stock units (RSUs) under the company's 2022 Omnibus Equity Incentive Plan.
  • On June 12, 2025, 5,000 shares of Agrify common stock were issued to Mr. Varier upon the settlement of previously granted restricted stock units, which were originally granted on November 19, 2024.
  • Following the settlement, Mr. Varier sold a total of 5,000 shares of Agrify common stock on June 12, 2025, across four separate transactions.
  • The sales occurred at weighted average prices ranging from $23.127 to $25.675 per share.
  • After all reported transactions, Mr. Varier beneficially owns 5,000 shares of Agrify common stock directly.

Sentiment

Score: 5

Explanation: The filing reports a routine insider transaction involving the vesting and subsequent sale of restricted stock units, which is a common practice and does not inherently indicate positive or negative sentiment about the company's performance or outlook.

Future Outlook

The 5,000 restricted stock units granted on June 11, 2025, are set to vest on the earlier of (i) the one-year anniversary of the grant date (June 11, 2026) or (ii) the next annual meeting of Agrify Corporation stockholders following the grant date, subject to continuous service.

Industry Context

This Form 4 filing details a routine insider transaction, common in publicly traded companies where executives and directors receive equity compensation that vests over time. The sale of shares immediately after vesting is a common practice, often to cover tax obligations or for personal liquidity, and does not necessarily reflect a change in the company's operational outlook or the director's confidence.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Power of Attorney GrantKrishnan Varier granted a Power of Attorney to Bret Kravitz, Kathryn A. Lloyd, and Brad Asher to prepare, execute, acknowledge, deliver, and file Section 16 filings (Forms 3, 4, and 5) with the SEC on his behalf.06/06/2025Streamlines the process for filing legally required insider transaction reports for the director, ensuring timely compliance with SEC regulations.

Related Party Transactions

  • The grant of restricted stock units to Krishnan Varier, a director, is a compensation-related transaction between the company and a related party.

Stakeholder Impact

  • Shareholders: The sale of 5,000 shares by a director represents a minor increase in the public float, which is unlikely to have a significant impact on liquidity or share price given the routine nature of the transaction.

Next Steps

  • The 5,000 restricted stock units granted on June 11, 2025, are expected to vest on the earlier of June 11, 2026, or the next annual meeting of stockholders.

Key Dates

DateDescription
11/19/2024Grant date of 5,000 restricted stock units that settled on June 12, 2025.
06/06/2025Effective date of the Power of Attorney granted by Krishnan Varier for SEC filings.
06/11/2025Grant date of 5,000 new restricted stock units to Krishnan Varier.
06/12/2025Settlement date of 5,000 restricted stock units (granted Nov 19, 2024) into common stock.
06/12/2025Date Krishnan Varier sold 5,000 common stock in multiple transactions.
06/13/2025Date the Form 4 was signed and filed with the SEC.

Keywords

Agrify Corp, AGFY, Form 4, Insider Transaction, Restricted Stock Units, RSU Vesting, Share Sale, Director, Krishnan Varier, Equity Incentive Plan

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.